LIVALO pitavastatin 1 mg film-coated tablet blister pack

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

지금 구매하세요

Download 공공 평가 보고서 (PAR)
29-11-2017

유효 성분:

pitavastatin calcium, Quantity: 1.045 mg (Equivalent: pitavastatin, Qty 1 mg)

제공처:

Advantage Medical Products Consulting Pty Ltd

INN (국제 이름):

pitavastatin calcium

약제 형태:

Tablet, film coated

구성:

Excipient Ingredients: hyprolose; titanium dioxide; triethyl citrate; hypromellose; colloidal anhydrous silica; magnesium stearate; lactose monohydrate; aluminium magnesium silicate

관리 경로:

Oral

패키지 단위:

100, 10, 30, 28

처방전 유형:

(S4) Prescription Only Medicine

치료 징후:

Livalo is indicated as an adjunct to diet for the treatment of adult patients with primary hypercholesterolaemia, including heterozygous familial hypercholesterolaemia, when response to diet and other non-pharmacological measures is inadequate. Prior to initiating therapy with Livalo, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.

제품 요약:

Visual Identification: Round biconvex white film-coated tablets embossed on one side with 'KC' and '1' on the other side; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

승인 상태:

Licence status A

승인 날짜:

2013-08-27